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sion: The mechanical sputum-processing method present-
ed had a similar yield of cells and fluids as the conventional 
DTT method and the advantage of omitting the introduc-
tion of reducing agents. This method allows a more reliable 
analysis of redox-dependent airway inflammation in spu-
tum cells and fluid from CF patients than methods utilizing 
DTT.  Copyright © 2009 S. Karger AG, Basel 
 Background 
 Cystic fibrosis (CF) is the most frequent hereditary 
disease in Caucasians  [1] caused by mutations in the 
CFTR (cystic fibrosis transmembrane conductance regu-
lator protein) gene  [2] . Although CF is a multiorgan dis-
ease, morbidity and mortality result mainly from pro-
gressive pulmonary disease  [3] . The lung involvement in 
CF is characterized by an excessive neutrophilic inflam-
mation in the airways associated with inflammatory 
markers, e.g. high levels of IL-8, elevated neutrophil elas-
tase (NE) activity  [4] , and increased oxidative damage  [5] . 
Past studies found that CFTR not only regulates the ef-
flux of chloride but also of other organic anions such as 
glutathione (GSH)  [6] . Previous data report that GSH 
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 Abstract 
 Background: Induced sputum is the most commonly used 
method to analyze airway inflammation in cystic fibrosis (CF) 
patients ex vivo. Due to the complex matrix of the sample 
material, precise and reliable analysis of sputum constitu-
ents depends critically on preanalytical issues.  Objectives: 
Here we compared the commonly used method for sputum 
processing by dithiothreitol (DTT) with a novel mechanical 
method in regard to basal cellular parameters, neutrophil 
markers and glutathione (GSH) levels.  Methods: Sputum 
samples from CF patients were processed in parallel with
or without the use of DTT. The key improvement of the 
 mechanical method was the processing in many very small 
aliquots. Cellular and humoral markers were assessed and 
compared according to Bland-Altman.  Results: Total cell 
count, cell viability, differential cell count, neutrophil elas-
tase levels and flow cytometrically analyzed neutrophil 
markers (CD63, CD11b, DHR) did not differ between the two 
methods. Intracellular and extracellular GSH levels were sig-
nificantly higher in DTT-treated samples (p = 0.002).  Conclu-
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concentrations are low in epithelial lining fluid of CF pa-
tients  [7, 8] . Elevation of GSH levels in type II alveolar 
epithelial cells downregulated the proinflammatory cy-
tokines IL-1  , IL-8 and tumor necrosis factor-   [9] . In 
clinical studies elevation of GSH levels by oral adminis-
tration of the GSH prodrug N-acetylcysteine in CF pa-
tients over 4 weeks decreased levels of IL-8 in induced 
sputum samples  [10] and a 2-week inhalation of GSH in 
CF patients decreased levels of the proinflammatory me-
diator PGE 2  [11] , while GSH depletion was associated 
with elevated oxidative stress-mediated proinflammato-
ry signaling  [12] . Further studies suggest that GSH down-
regulates inflammatory response by inhibiting tran-
scription factors such as NF-  B or AP-1  [13, 14] . Thus, in 
addition to its antioxidant property GSH plays a key role 
in immune responses  [14] .
 In the past years, induced sputum samples are increas-
ingly used, as they are a useful and minimal invasive tool 
to monitor pulmonary diseases  [15–22] . Because of the 
high viscosity induced sputum samples of CF patients 
need to be dispersed before analysis. Among several 
methods evaluated, the method utilizing dithiothreitol 
(DTT) is widely used because of its ability to split disul-
fide bonds and disperse sputum samples  [15] . However, 
due to its reducing and denaturing effect DTT has been 
shown to preanalytically affect levels of various media-
tors  [23–28] and it is most likely that DTT also influenc-
es oxidant-dependent variables like GSH.
 Several studies have assessed GSH levels in induced 
sputum samples of patients with various pulmonary dis-
eases including CF  [29] , asthma  [25, 30] , and COPD  [31, 
32] without the use of DTT for sample processing. Though 
one study demonstrated an effect of DTT on the assay 
used for GSH measurements  [30] , none of these studies 
systematically compared methods with and without the 
use of DTT to assess changes in intra- and extracellular 
GSH levels and to analyze the impact on other relevant 
cellular parameters.
 Our laboratory established a mechanical method 
without the use of DTT (hereinafter referred to as ‘D-PBS 
method’) for sputum processing to investigate oxidative 
state and inflammation in CF-induced sputum samples. 
Here we compared the new method with the convention-
al DTT method and the results show equivalence for bas-
al cellular variables and superiority for extracellular and 
intracellular GSH measurements, which are artificially 
elevated by the DTT method. These results are clinically 
relevant and very important for the increasing number of 
studies analyzing airway inflammation in CF patients via 
sputum induction.
 Material and Methods 
 Study Design 
 The study was approved by the institutional review board of 
the University of Munich and informed consent from all CF sub-
jects was obtained prior to the study. Induced sputum samples 
from 10 CF patients were used in this study. Following the appli-
cation of 200   g of the   2 -sympathomimetic salbutamol, subjects 
inhaled hypertonic saline solution (5.85%) for 15 min using a Pari 
Boy SX combined with an LC Sprint jet nebulizer (Pari, Munich, 
Germany). To avoid contamination, saliva was expectorated into 
a separate container. Patients were encouraged to produce spu-
tum samples at 5-min intervals. The first portion was used for 
microbiological analyses. Subsequent portions were transported 
to the laboratories on ice. Plugs were selected with forceps and the 
sample was divided into two approximately equal aliquots and 
processed within 30 min side by side in two ways. One aliquot was 
homogenized with 4 times the volume of D-PBS and 5 times the 
volume of 10% DTT (Calbiochem, Darmstadt, Germany) in a 
shaking water bath with 37 ° C for 15 min as routinely used and 
previously described  [33] . The other aliquot was divided with two 
sterile blunt forceps into small portions of approximately 0.2 g 
and 9 times the volume of D-PBS was added. Samples were ho-
mogenized by gentle passage repeated 20 times through an 18-
gauge needle. For some experiments, a further aliquot was divid-
ed and homogenized with 4 times the volume of D-PBS and 5 
times the volume of 10% DTT on ice for 15 min.
 The following steps were carried out in parallel for both meth-
ods. Homogenized samples were consecutively filtered through a 
100- and 40-  m cell strainer and centrifuged at 300  g and 4 ° C for 
10 min.
 The supernatant was carefully transferred into other vials and 
centrifuged again at 10,000  g and 4 ° C for 5 min. The supernatant 
was pooled and divided into Eppendorf cups. One part was im-
mediately frozen at –80 ° C until analysis. The other part was used 
for determination of thiols. To assess free GSH levels, samples 
were precipitated with trichloroacetate (Sigma-Aldrich, Munich, 
Germany) and centrifuged at 1,500  g and 4 ° C for 5 min. The su-
pernatant was frozen immediately at –80 ° C until analysis. To 
measure total GSH levels, tributylphosphine (Sigma-Aldrich) 
buffer was added, and samples were incubated for 30 min at 4 ° C. 
Then the samples were precipitated and centrifuged at 1,500  g and 
4 ° C for 5 min. The supernatant was frozen immediately at –80 ° C 
until analysis.
 Cell suspension was resuspended with D-PBS, total cell count 
was determined in a Neubauer chamber and cell viability was as-
sessed with the trypan blue exclusion method. Cytospin slides for 
differential cell counts with 30,000 cells per slide were prepared, 
fixed and stained according to May-Grünwald-Giemsa. The re-
maining cell suspension was diluted to 10 6 cells/ml and was used 
for FACS analysis.
 Measurement of GSH Levels in Sputum Supernatant 
 Thawed samples were derivatized with 7-fluorobenzofura-
zan-4-sulfonic acid ammonium salt (SBD-F; Fluka, Munich, Ger-
many) in boric acid (Merck, Darmstadt, Germany) buffer and 
were incubated at 60 ° C for 1 h as described previously  [34] . Sam-
ples were stored at 4 ° C until analyzed by means of reversed-phase 
HPLC (RP-HPLC) within 24 h. Kuhn et al.  [34] gave a de tailed 
description of the running conditions. Standard measurements 
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were performed after analysis of ten samples. All runs were per-
formed in duplicate. If deviation of duplicates was greater than 5% 
a third run was carried out. The mean deviation of the duplicates 
was 3.2% within a range of 0.2–7.1%. GSH concentrations were 
calculated with respect to GSH standard measurements which 
were carried out after every tenth sample. Intra-assay and inter-
assay variability of the GSH standards were tested by linear re-
gression (r 2 = 0.997 and r 2 = 0.97, respectively). In previous tests 
recovery experiments were performed by spiking and the mean 
recovery rate was 94% within a range of 87.6–99.6%.
 FACS Analyses 
 Monoclonal fluorochrome-labeled antibodies were pur-
chased from BD Pharmingen (Heidelberg, Germany) unless oth-
erwise specified. Markers of interests were CD63, CXCR1, CD11b, 
CD15s, Cam5.2, CD3 and CD4. To assess intracellular respira-
tory burst we used the dihydrorhodamine (DHR) 123 (AnaSpec/
MoBiTec, Göttingen, Germany) method  [29] . Intracellular GSH 
levels were measured with monochlorobimane (Fluka)  [10, 35] . 
Samples were measured with an FACSCalibur (Becton Dickin-
son, Heidelberg, Germany) and an FACS Canto II (Becton Dick-
inson). Results were analyzed with Cell Quest software version 
1.3 (Becton Dickinson) and BD FACS Diva (Becton Dickinson) 
software, respectively. The results are given in mean fluorescence 
intensity. We used annexin V and propidium iodide to exclude 
apoptotic (annexin V+/propidium iodide–) and necrotic (annex-
in V+/propidium iodide+) cells from analysis as well as isotype 
controls to exclude nonspecific bindings. For DHR, monochlo-
robimane, annexin V, and propidium iodide negative controls 
were applied.
 Measurement of NE 
 NE was analyzed in sputum supernatant by a chromogenic 
spectrophotometric assay as described elsewhere  [36] .
 Statistical Analysis 
 Agreement between the two methods was analyzed by the 
Bland-Altman method  [37] . The difference of the two methods 
(bias) is analyzed as a function of the mean of the two measure-
ments of each sample. If the two methods produce the same result, 
the average of the bias will be close to zero. Agreement was con-
sidered to be acceptable if differences of means were approximate-
ly 5% or less.
 Means and standard error of means or ranges are given for each 
variable. The sputum processing protocols were compared for dif-
ferences with the nonparametric Wilcoxon-signed rank test for 
paired values. p  ! 0.05 was considered statistically significant.
 Results 
 Patient Characteristics 
 Ten patients with CF were included in this study, 4 of 
whom were males (mean age 31.1 years, ranging from 22 
to 41 years). Nine patients were infected with  Pseudomo-
nas aeruginosa . Mean FEV 1 (% of predicted) was 54.8% 
(range: 24.8–87.4%). All patients were stable and none 
had pulmonary exacerbations as defined by Fuchs et al. 
 [38] within the preceding 4 weeks. No adverse events, i.e. 
bronchoconstriction, occurred due to the induced spu-
tum procedure.
 Cell Count and Cell Viability 
 The amount of sputum obtained was sufficient in all 
subjects and the average weight was 1.6 g (range: 0.679–
2.23 g). There was no statistically significant difference 
for total cell count, differential cell count, and cell viabil-
ity for the D-PBS and DTT method ( table 1 ). Agreement 
of the two methods was high for neutrophils, but rela-
tively low for other cellular subpopulations ( table 2 ).
 Neutrophil Markers 
 In the set of neutrophil surface markers used in this 
study and respiratory burst in neutrophils no significant 
difference was found for both methods ( fig. 1 ). The agree-
ment of the two methods was acceptable for CD63, CD11b, 
and DHR123, whereas it was relatively low for CXCR1 
( table 2 ). NE levels in samples treated with DTT were 
comparable to those treated with PBS and the agreement 
of the two methods was good ( fig. 2 ;  table 2 ).
 Intracellular GSH Levels 
 Cell type-specific intracellular levels of GSH were an-
alyzed by flow cytometry. All samples were sufficient for 
measurement of neutrophils and epithelial cells. In neu-
trophils and epithelial cells intracellular GSH levels were 
significantly higher in DTT-treated samples compared to 
Table 1. Comparison of methods of processing sputum samples
Methods
D-PBS DTT
Used weight, g 0.70 (0.35–0.86) 0.71 (0.3–0.93)
Total cell count 
106 cells/ml 6.47 (2.15–10.76) 6.51 (3.06–11.56)
Differential cell counts, %
Neutrophils
Eosinophils
Basophils
Macrophages
Lymphocytes
96.89 (92.5–99.3)
0.26 (0.0–2.3)
0.19 (0.0–1.0)
0.94 (0.0–2.0)
1.35 (0.0–4.5)
97.06 (87.5–99.7)
0.21 (0.0–1.8)
0.31 (0.0–1.5)
1.18 (0.0–6.0)
1.18 (0.0–5.0)
Cell viability, % 83.7 (77–92) 83.5 (72–88)
All data are given as means (with the range in parentheses) 
from 10 different subjects. No significant differences were found 
for investigated variables.
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D-PBS-treated samples (p = 0.002). In line with these 
data, the agreement between the two methods was not 
acceptable, suggesting that the thiol-independent meth-
od of sample preparation should be used if intracellular 
GSH is assessed ( table 2 ). In lymphocytes the number of 
events detected was too low in 3 samples to assess the D-
PBS method and in 4 samples to assess the DTT method. 
These samples were not included in the analyses and the 
numbers were too low to reach the significance level set 
before ( fig. 3 ).
 Independent of the processing method, intracellular 
GSH levels were lower in neutrophils than in lympho-
Table 2. Bland-Altman agreement of methods of processing spu-
tum samples 
Bias, % difference of the 
two methods compared
Basal cellular parameters
Total cell count 5.585.5
Cell viability –0.981.6
Differential cell count
Neutrophils 0.180.7
Basophils –12.2812.2
Eosinophils 29.5866.6
Lymphocytes –21.4838.8
Monocytes –41.4825.2
Neutrophil elastase
Concentration in supernatant 2.384.6
Concentration per neutrophil –3.687.0
Neutrophil markers in flow cytometry
CD63 –0.6813.9
CXCR1 34.7832.3
CD11b 7.385.5
DHR –0.987.1
Intracellular GSH levels
Neutrophils 138.3814.5
Lymphocytes 150.3816.7
Epithelial cells 86.9815.0
Extracellular GSH levels
Free GSH 105.987.2
Total GSH 4.785.1
Ratio free/total GSH 102.487.3
Summary of the comparison according to Bland-Altman of 
the two methods is given, i.e. the novel mechanical sputum 
processing method and the conventional DTT method. For easy 
comparison the % of bias and their standard error of mean are 
given. A total of 10 pairs were analyzed except for intracellular 
GSH levels in lymphocytes, where only in 5 sample pairs the num-
bers of events were appropriate to perform FACS analysis.
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 Fig. 1. FACS analysis of neutrophil markers and respiratory burst. 
Mean fluorescence intensity of CD63, CXCR1, CD11b, and DHR 
on neutrophilic granulocytes in IS samples processed with either 
D-PBS or DTT (n = 10) is shown. CD63 is a specific marker for 
intracellular primary granules containing active substances like 
myeloperoxidase and NE and is expressed on the surface by fu-
sion of the granules with the cell membrane  [10] . CXCR1 is a well-
known receptor for the proinflammatory chemokine IL-8, which 
is abundant in airway fluids of CF patients. CD11b is expressed 
on neutrophils after diapedesis into the airways and is also 
thought to play a role in the phagocytosis activity of neutrophils 
 [4] . None of the markers differed significantly between the two 
processing methods. Agreement was good for CD63 and DHR 
and acceptable for CD11b, whereas for CXCR1 it was poor. 
 Fig. 2. NE levels. NE concentrations (left y-axis) in sputum super-
natant and NE concentrations normalized to neutrophil counts 
(right y-axis) are given. There was no significant difference be-
tween the two methods. In one sample pair NE was not detectable 
(n = 10). 
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cytes and epithelial cells (p  ! 0.05 and p = 0.002, respec-
tively). The latter two cell types had comparable intracel-
lular GSH levels ( fig. 3 ).
 Assessment of Extracellular GSH by RP-HPLC 
 Extracellular free GSH levels were significantly higher 
in samples treated with DTT compared to those pro-
cessed with D-PBS (p = 0.002). The levels of free GSH in 
samples treated with DTT were comparable with total 
GSH levels in samples treated with both methods. Mean 
ratio of free/total GSH was 31% (range: 15.8–41.5%) and 
95.6% (range: 82.7–108.6%) in samples treated with D-
PBS and DTT, respectively ( fig. 4 ). In concordance with 
these results, the agreement of the two methods was poor 
( table 2 ), clearly showing an about 100% significant in-
crease in free extracellular GSH and intracellular GSH 
(see above) after treatment with DTT. As expected, total 
GSH measured after complete reduction of the sample, 
which leads to availability of all thiol groups in the sam-
ples, showed comparable levels and good agreement of 
the two methods ( table 2 ).
 There Are No Temperature-Driven Effects on 
Determination of GSH 
 To exclude temperature-driven effects of DTT on GSH 
measurements, 4 induced sputum samples of CF patients 
were processed as mentioned above (1) by the presented 
method using D-PBS, (2) with DTT at 37 ° C, and (3) ad-
ditionally with DTT on ice. The effect of DTT on GSH 
measurements was similar for both temperature condi-
tions. These results indicate that the determination of 
GSH was not dependent on the temperature at which
the preparation of sputum was done in the presence of 
DTT. Thus, elevated GSH levels were due to the addition 
of DTT (for all online supplementary data, see www.
karger.com/doi/10.1159/000271607.
 Discussion 
 Induced sputum is the most commonly used noninva-
sive method to analyze airway inflammation in CF pa-
tients ex vivo, but owing to the complex matrix of the 
sample material, precise and reliable analysis of sputum 
constituents depends critically on preanalytical issues. 
Here, we systematically compared the conventional 
method used for sputum processing by DTT with a nov-
el method developed in our laboratories and demonstrat-
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 Fig. 4. Extracellular GSH levels. Extracellular levels for free and 
total GSH (left y-axis) and the ratio of free/total GSH (right y-axis) 
measured in induced sputum supernatant by RP-HPLC are given. 
Free GSH levels and the ratio of free/total GSH were significant-
ly higher with the DTT method compared to the D-PBS method 
(p = 0.002; n = 10). 
 Fig. 3. Intracellular GSH levels. Comparison of GSH levels intra-
cellularly assessed by FACS is shown. Intracellular GSH levels in 
samples processed with the DTT method were significantly high-
er in neutrophil granulocytes and epithelial cells (p = 0.002; n = 
10). In lymphocytes, counted events in 3 samples processed with 
D-PBS and 5 samples processed with DTT were too low and were 
taken out of analysis. Statistically, there was only a tendency of 
higher intracellular GSH levels in lymphocytes in DTT samples 
compared to D-PBS samples (p = 0.06). Cam5.2 is a pan-epithe-
lial marker  [46] , CD15s is expressed on granulocytes, while CD3 
and CD4 are well-known markers for T cells. These markers were 
used for classification of the cell populations. 
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ed that the presented sputum processing method is supe-
rior to the conventional DTT method, in particular for 
measuring redox-dependent parameters, such as GSH, in 
sputum samples. These results are novel and clinically 
relevant for the increasing number of studies analyzing 
airway inflammation in CF patients via sputum induc-
tion.
 DTT is a strong reductant which disrupts the sputum 
matrix that is stabilized by disulfide bonds and thus al-
lows the liberation and analysis of cells and solutes. How-
ever, several studies pointed out effects of DTT on vari-
ous markers  [23, 25–28] . In this study we systematically 
analyzed the effects of the standard DTT sputum pro-
cessing method on various cellular variables as well as on 
extra- and intracellular GSH levels in comparison to a 
novel method using mechanical disruption of very small 
aliquots of the samples. Viability, number of total cells 
recovered and cell differential were not significantly dif-
ferent between the two methods. The Bland-Altman 
analysis revealed that the agreement between the DTT 
method and the mechanical method was appropriate for 
total cell count, cell viability and differential cell count 
for neutrophils while it was low for differentials of other 
cell types. This was most likely due to the small numbers 
of the other cell types in investigated induced sputum 
samples ( tables 1 ,  2 ). However, free extracellular and in-
tracellular GSH levels were significantly higher in sam-
ples treated with DTT. Agreement analyses also revealed 
significant differences in extracellular and intracellular 
GSH measurements except for measurements of extracel-
lular total GSH ( table 2 ). This result may be expected be-
cause of the reducing capacity of DTT in releasing GSH 
from disulfide bonds in the same manner as tributylphos-
phine which we used to detect total GSH levels in our 
method. This altering effect of DTT was already shown 
in a previous study for extracellular GSH concentrations 
in induced sputum samples of patients with asthma  [25] , 
but to the authors’ knowledge an alteration of intracellu-
lar GSH levels, i.e. the intracellular redox potential, has 
not been shown until now.
 The alteration of GSH levels by DTT shown in this 
study could also be due to interference of DTT with the 
method for GSH measurements. Previous studies have 
shown significant effects of DTT on GSH measurements 
by a spectrophotometric method using the reagent DTNB 
which was – at least in part – due to the reduction of 
DTNB itself by DTT  [25, 29, 30] . As for the RP-HPLC 
method we used for the present study, Kuhn et al.  [34] 
 previously reported that the reaction of DTT and SBD-F 
yields fluorescent by-products. To exclude possible inter-
ference, blanks with or without the addition of DTT were 
analyzed. Latter measurements revealed unspecific peaks 
after retention times of approximately 6.5–6.8 and 7.8–
8.5 min in the presence of DTT. As the peak for GSH ap-
pears at approximately 8.6–8.9 min, the by-products 
should not or only minimally interfere with our GSH 
measurements (online suppl. data). This is also supported 
by our results on total GSH levels which were comparable 
with samples processed with and without DTT, indicat-
ing that there was no significant interference of DTT with 
the RP-HPLC assay we used in this study ( fig. 4 ). Addi-
tionally, monochlorobimane – which was used for detec-
tion of intracellular GSH in the present study – is a non-
fluorescent probe which is able to permeate living cells 
and specifically links to GSH via glutathione-S-transfer-
ase resulting in the fluorescent adduct glutathione-S-bi-
mane  [10] . The specificity of the intracellular enzyme sys-
tem makes it unlikely that other DTT by-products are 
detected by this method. The results we obtained with the 
RP-HPLC method and with the flow cytometry method 
with monochlorobimane were consistent. Taken togeth-
er, our results indicate that higher levels of GSH in DTT-
treated samples result from the ability of DTT to break 
up disulfide bonds of protein disulfide (RS-SG).
 In a previous comparative study using DTT or D-PBS 
for the preparation of sputum samples from patients with 
asthma, cell viability was higher with the D-PBS method 
while total cell count was higher when samples were pro-
cessed with DTT  [15] . The use of an optical isomer of 
DTT, dithioerythritol, also yielded a higher recovery of 
total cells compared to D-PBS  [23] . However, in our study 
there was no significant difference and agreement was ac-
ceptable between the two methods regarding the means 
of cell count, cell differential and cell viability. The critical 
step responsible for the improved recovery by our method 
was the homogenization step. In pilot experiments we 
found that it is critical to divide the sputum aliquots into 
further small portions not larger than approximately 0.2 
g and to homogenize these by gentle aspiration and dis-
persion in a 9-fold volume of D-PBS. Such a procedure was 
omitted in earlier studies. Previously, the authors treated 
the samples with PBS without any further homogenizing 
step  [15] . Louis et al.  [23]  reported that sputum samples 
were agitated for 10 s and rocked for a further 30 min for 
either method. In case only PBS is used it is questionable 
whether this is enough to disperse cells in highly viscous 
sputum samples like those of CF patients.
 The effect of DTT on the measurement of NE levels was 
tested in studies with a cohort of patients with CF  [39] and 
chronic obstructive pulmonary disease  [40] . No signifi-
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cant changes were reported, which is in accordance with 
our findings. NE levels and levels normalized to neutro-
phil numbers in supernatant as assessed by Bland-Altman 
analysis were comparable for both methods ( table 2 ).
 As for the effect of DTT on surface markers and respi-
ratory burst in neutrophils as assessed by flow cytometry 
in this study, to the authors’ knowledge there have so far 
been no comparative studies. However, in this study DTT 
had no effect on CD63 and DHR, but a small effect on 
CD11b and a significant effect on CXCR1 measurements 
when compared to the D-PBS method. A possible expla-
nation for the increased CXCR1 expression found on the 
neutrophil surface after DTT treatment could be the 
higher accessibility of anti-CXCR1 antibodies to the 
binding site. Within CXCR1, an extracellular disulfide 
bond exists between the N-terminus and the first extra-
cellular loop  [41] . DTT could break down this disulfide 
bond and change the conformation and antibody acces-
sibility of the receptor.
 In a previous study, our laboratory showed that DTT 
had no effect on measurements of the cytokines IL-1  
and tumor necrosis factor-  , the leukotriene LTB 4 , and 
the chemokine IL-8 in sputum samples from patients 
with CF (online suppl. data)  [42] . Similarly, other studies 
did not find altered levels of IL-8 in sputum samples 
treated with either DTT or dithioerythritol compared to 
PBS in patients with asthma  [15, 23] . In contrast, other 
studies did find DTT-dependent changes in measured 
levels of IL-8 as assessed by ELISA  [40, 43] and in a range 
of cytokines and chemokines as analyzed by a multiplex 
bead array immunoanalysis  [26] . However, in an exten-
sive review of Kelly et al.  [28]  most of these markers were 
shown to be unaffected by DTT. Neverthelss, the ratio of 
the redox pair GSH/GSH disulfide (GSSG) is known to 
play an important role in the activation of the proinflam-
matory transcription factor NF-  B  [44] . Elevation of in-
tracellular GSH levels and GSH/GSSG ratio resulted in 
the inhibition of NF-  B activation  [45] . Although it seems 
unlikely that the short incubation time (i.e. 15 min) of 
sputum samples with DTT exerts effects on the NF-  B-
driven inflammatory response, to the authors’ knowl-
edge short-term effects of DTT on inflammatory path-
ways have never been investigated until now. 
 Conclusions 
 We developed a novel mechanical method processing 
many small portions of induced sputum samples. We 
show that this method is equivalent to the commonly 
used DTT method for measurement of many cellular and 
fluid phase variables in sputum samples. Additionally, 
the D-PBS method – in contrast to the DTT method – 
does not affect redox-dependent variables such as GSH. 
These results are novel and clinically relevant for the in-
creasing number of studies analyzing airway inflamma-
tion in CF patients via induced sputum.
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